Skip to main content
. 2023 Jan 30;15(2):460. doi: 10.3390/pharmaceutics15020460
ADAS-cog Alzheimer’s Disease Assessment Scale-cognitive
AIC Akaike Information Criteria
BMMS Baseline Mini-Mental State
cLRT Combined Likelihood Ratio Test
dOFV Difference in Objective Function Value
IIV Inter-Individual Variability
IMA Individual Model Averaging
LRT Likelihood Ratio Test
MAD Model Averaging Across Drug models
MAPD Model Averaging Across Placebo and Drug models
NLMEM Non-Linear Mixed Effects Models
OFV Objective Function Value
rcLRT Randomized Combined Likelihood Ratio Test
RMSE Root Mean Squared Error
RUV Residual Unexplained Variability
SSs structural similarity selection
STDs Standard model selection